Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jan 14, 2018; 24(2): 266-273
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.266
Table 4 Comparison of response, liver metastasis rate, and overall survival between alpha-fetoprotein ≥ 160 ng/mL and alpha-fetoprotein < 160 ng/mL groups n (%)
VariableAFP ≥ 160 ng/mLAFP < 160 ng/mLP value
Overall ORR
PR14 (30.4)28 (68.3)< 0.001a
SD + PD32 (69.6)13 (31.7)
ORR to doublet regimens
PR10 (26.3)26 (70.3)< 0.001a
SD + PD28 (73.7)11 (30.7)
ORR to triplet regimens
PR4 (57.1)2 (50.0)0.652
SD + PD3 (42.9)2 (50.0)
Liver metastasis rate69.8%50.0%0.030a
Median OS13.0 mo14.8 mo0.712